Genentech announced positive results from the Phase III study (REGENCY) of Gazyva (Obinutuzumab) for people with active lupus nephritis (LN).
In a new study, researchers looked to identify unique biomarkers and shared microbial mechanisms among different autoimmune ...
We're introducing a new series of personal stories about living with lupus. Each month we will highlight someone living with lupus, sharing as little or as mush as they would like according to their ...
UCB and Biogen have announced positive Phase III clinical trial results for PHOENYCS GO study, evaluating dapirolizumab pegol, a new treatment for moderate-to-severe systemic lupus erythematosus (SLE) ...
La mayoría de los niños con lupus verán a un reumatólogo pediátrico. Los reumatólogos pediátricos se especializan en el diagnóstico y tratamiento de niños con enfermedades autoinmunes, como el lupus, ...
Cullinan Therapeutics has filed an investigational new drug application with the U.S. Food and Drug Administration (FDA) for CLN-978 for the treatment of systemic lupus erythematosus (SLE).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback